Vistagen to participate in fireside chat at maxim group 2022 virtual growth conference

South san francisco, calif., march 24, 2022 (globe newswire) -- vistagen therapeutics, inc. (nasdaq: vtgn) (vistagen), a late clinical-stage, neuro-focused biopharmaceutical company striving to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (cns) disorders, today announced that chief executive officer shawn singh will participate in a fireside chat with maxim analyst jason mccarthy, ph.d., on monday, march 28, 2022, at 2:00 p.m. pacific time during the maxim group 2022 virtual growth conference.
VTGN Ratings Summary
VTGN Quant Ranking